Adnan X, Suheimat Marwan, Mathur Ankit, Efron Nathan, Atchison David A
School of Optometry & Vision Science and Institute of Health & Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove Q 4059, Australia.
Biomed Opt Express. 2015 Mar 13;6(4):1282-92. doi: 10.1364/BOE.6.001282. eCollection 2015 Apr 1.
Straylight, lens yellowing and ocular aberrations were assessed in a group of people with type 1 diabetes and in an age matched control group. Most of the former had low levels of neuropathy. Relative to the control group, the type 1 diabetes group demonstrated greater straylight, greater lens yellowing, and differences in some higher-order aberration co-efficients without significant increase in root-mean-square higher-order aberrations. Differences between groups did not increase significantly with age. The results are similar to the findings for ocular biometry reported previously for this group of participants, and suggest that age-related changes in the optics of the eyes of people with well-controlled diabetes need not be accelerated.
对一组1型糖尿病患者和年龄匹配的对照组进行了散射光、晶状体变黄和眼像差评估。前者大多数神经病变水平较低。与对照组相比,1型糖尿病组表现出更大的散射光、更严重的晶状体变黄,并且一些高阶像差系数存在差异,但均方根高阶像差没有显著增加。组间差异不会随年龄显著增加。这些结果与之前报道的该组参与者的眼生物测量结果相似,表明血糖控制良好的糖尿病患者眼睛光学的年龄相关变化不一定会加速。